The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 22, 2019

Filed:

Nov. 24, 2014
Applicant:

The University of Nottingham, Nottingham Nottinghamshire, GB;

Inventors:

Nigel Peter Minton, Nottingham, GB;

John Timothy Heap, Nottingham, GB;

Assignee:

THE UNIVERSITY OF NOTTINGHAM, Nottinghamshire, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 38/44 (2006.01); A61K 31/396 (2006.01); A61K 35/742 (2015.01); A61K 9/00 (2006.01); C12N 15/74 (2006.01); C12N 9/06 (2006.01); A61K 35/745 (2015.01);
U.S. Cl.
CPC ...
A61K 38/44 (2013.01); A61K 9/0019 (2013.01); A61K 31/396 (2013.01); A61K 35/742 (2013.01); A61K 35/745 (2013.01); C12N 9/0028 (2013.01); C12N 15/74 (2013.01); C12Y 105/01034 (2013.01);
Abstract

The present invention provides a method of treatment for cancer in a subject comprising the administration of a prodrug, wherein the subject is colonised with an obligate anaerobic microorganism capable of expressing a polypeptide having nitroreductase activity, wherein the polypeptide exhibits preferential reduction of CB1954 to a 4-hydroxylamine (4HX) derivative instead of a 2-hydroxylamine derivative; and is capable of reducing CB1954 to the 4HX derivative with a Kof less than 30 micromolar. The present invention further provides an isolated polypeptide, nucleic acids encoding said polypeptide, vectors and host cells comprising said nucleic acids and vectors and uses of the above in treating solid tumours.


Find Patent Forward Citations

Loading…